Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

424 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy of switching from infliximab biosimilar CT-P13 to infliximab biosimilar SB2 in patients with inflammatory bowel disease.
Lovero R, Losurdo G, La Fortezza RF, Terracciano F, Biscaglia G, Martino G, Nardella M, Di Leo A, Principi M, Andriulli A, Bossa F. Lovero R, et al. Among authors: andriulli a. Eur J Gastroenterol Hepatol. 2021 Feb 1;32(2):201-207. doi: 10.1097/MEG.0000000000001988. Eur J Gastroenterol Hepatol. 2021. PMID: 33369956
Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs.
Bossa F, Carparelli S, Latiano A, Palmieri O, Tavano F, Panza A, Pastore M, Marseglia A, D'Altilia M, Latiano T, Corritore G, Martino G, Nardella M, Guerra M, Terracciano F, Sacco M, Perri F, Andriulli A. Bossa F, et al. Among authors: andriulli a. Dig Liver Dis. 2021 Mar;53(3):277-282. doi: 10.1016/j.dld.2020.12.120. Epub 2021 Jan 6. Dig Liver Dis. 2021. PMID: 33423942 Free PMC article.
Genome-wide Pathway Analysis Using Gene Expression Data of Colonic Mucosa in Patients with Inflammatory Bowel Disease.
Palmieri O, Creanza TM, Bossa F, Palumbo O, Maglietta R, Ancona N, Corritore G, Latiano T, Martino G, Biscaglia G, Scimeca D, De Petris MP, Carella M, Annese V, Andriulli A, Latiano A. Palmieri O, et al. Among authors: andriulli a. Inflamm Bowel Dis. 2015 Jun;21(6):1260-8. doi: 10.1097/MIB.0000000000000370. Inflamm Bowel Dis. 2015. PMID: 25901971 Free PMC article.
The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar.
Fiorino G, Manetti N, Armuzzi A, Orlando A, Variola A, Bonovas S, Bossa F, Maconi G, DʼIncà R, Lionetti P, Cantoro L, Fries W, Annunziata ML, Costa F, Terpin MM, Biancone L, Cortelezzi CC, Amato A, Ardizzone S, Danese S, Guidi L, Rizzuto G, Massella A, Andriulli A, Massari A, Lorenzon G, Ghione S, Kohn A, Ventra A, Annese V; PROSIT-BIO Cohort. Fiorino G, et al. Among authors: andriulli a. Inflamm Bowel Dis. 2017 Feb;23(2):233-243. doi: 10.1097/MIB.0000000000000995. Inflamm Bowel Dis. 2017. PMID: 28092307
Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis.
Bossa F, Biscaglia G, Valvano MR, Costantino G, Lauria A, Clemente R, Ferracane C, Shahini E, Mendolaro M, Grossi L, Mazzuoli S, Rispo A, Pranzo G, Sebkova L, Tursi A, Miranda A, Patturelli M, Spagnuolo R, Ricciardelli C, Sgarro C, Paese P, Inserra G, Azzarone A, Nardone O, Fries W, Buccianti N, Privitera AC, Principi MB, Cappello M, Guglielmi FW, Romano M, Riegler G, Fanigliulo L, Melina R, Andriulli A. Bossa F, et al. Among authors: andriulli a. Dig Dis Sci. 2020 Jun;65(6):1767-1776. doi: 10.1007/s10620-019-05904-z. Epub 2019 Nov 13. Dig Dis Sci. 2020. PMID: 31722059
424 results